doi: 10.3389/fphar.2025.1602976 Received 30 March 2025 Revised 13 November 2025 Accepted 14 November 2025 Published 19 December 2025 Volume 16 - 2025 Edited by Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa Reviewed by Kacper Nijakowski, Poznan University of Medical Sciences, Poland Miriam Njoki Karinja, Science for Africa Foundation, Kenya Updates Copyright 2025 Mazur, Ndokaj, Salerno, Vallone, Ardan, Bietolini, Carrouel, Wilk, Sarig, Ottolenghi and Bourgeois
The case for Glutathione If NAD+ is the cells battery, Glutathione is its shield
Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary
There is no available information regarding the use of this medication in children
For those managing multiple peptide stacks , this organizational system becomes even more critical
We promise that the results are worth it